ArticleAdvances in therapy2021

A Clinical and Budgetary Impact Analysis of Introducing Sugammadex for Routine Reversal of Neuromuscular Blockade in a Hypothetical Cohort in the US.

Yiling Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.